B Capital and CalPERS Just Bought Russell Investments. Here's Why That Matters More Than the Price Tag
According to Axios , B Capital and CalPERS agreed on July 9 to buy Russell Investments from TA Associates and Reverence Capital Partners in a deal reportedly worth $2.8 billion. Russell manages...
July 11, 2026
Activist Hedge Fund Investing: How Shareholder Activists Force Change and Unlock Value
Elliott Management spent two months in private talks with Synopsys (NASDAQ: SNPS) before the chip-design software maker agreed, on May 26, 2026, to put Elliott partner Jesse Cohn on its board....
July 11, 2026
Subscription Lines of Credit: How Sub Lines Distort Reported PE/VC Fund IRR
A six-month delay in calling capital can add close to two full percentage points to a private equity fund's reported IRR without changing a single dollar of profit. According to the Kenan...
July 11, 2026
Arrived Homes Review: Fees, Realized Dividends, and the 2024 Washington Consent Order
TL;DR: Arrived Homes lets you buy fractional shares of single-family rental houses for as little as $100, no accreditation required, and it has real backers (Jeff Bezos, through Bezos Expeditions)....
July 10, 2026
SEC's Proposed Regulation Crypto: Three Exemption Pathways and the Section 11 Gap Investors Need to Know
TL;DR: The SEC is drafting a proposed rule called Regulation Crypto that would create three separate fundraising pathways for token issuers: a Startup Exemption capping raises around $5 million over...
July 10, 2026
Fundrise Innovation Fund (VCX) Review: A 1,500% NAV Premium You Shouldn't Buy
TL;DR: Fundrise Innovation Fund converted from a quarterly tender-offer fund into an NYSE-listed closed-end fund (ticker VCX) on March 19, 2026. Shares traded as high as roughly $315 against a net...
July 10, 2026
Private Equity Secondaries Hit $226-240B in 2025: What the Discount-to-NAV Data Really Shows
TL;DR: The private equity secondary market hit a record $226 billion to $240 billion in 2025, up 41% to 48% year over year, depending on whether you trust Evercore's or Jefferies' count. Roughly half...
July 10, 2026
How to Read a Private Placement Memorandum: Red Flags Before You Wire Money
TL;DR: A private placement memorandum is not reviewed, approved, or fact-checked by the SEC before it lands in your inbox. In 2025 alone, four Reg D sponsors raised a combined $489M from investors...
July 10, 2026
Blue Owl's £1.3bn UK Hospital Deal: What It Signals for Net-Lease Income Investors
TL;DR: Blue Owl Capital just closed a £1.3bn (~$1.65B) acquisition of 12 acute-care hospitals from Spire Healthcare Group plc, buying the real estate out of a sale-and-leaseback structure previously...
July 10, 2026
Pharmaceutical Royalty Investing: How Royalty Pharma Makes This Alt Asset Public
TL;DR: Royalty Pharma (NASDAQ: RPRX) is a $31.6-33.3 billion company that buys the right to a slice of future drug sales, and you can own it through any ordinary brokerage account for the price of...
July 10, 2026
Carbon Credit Investing for Accredited Investors: Compliance Markets, KRBN, and the Quality Split Reshaping the VCM in 2026
TL;DR: Carbon credits split into two markets that behave nothing alike. Compliance credits (EU ETS, California Cap-and-Trade, RGGI) trade on regulated exchanges and you can buy exposure through an...
July 10, 2026
Lyzr Let Its AI Agent Run a $100M Raise. Who Checked What It Said?
TL;DR: Lyzr, an AI agent startup, let its own agent named SivaClaw field questions from more than 130 investors and draft investment memos during its $100M Series B raise. The round priced at roughly...
July 10, 2026